,trastuzumab deruxtecan
astrazeneca,daiichi sankyo
['destiny-04', 'bcsm']
standing ovation after destiny-04 trial results presentation at plenary session #asco22 #bcsm 
Medical Oncology Fellow @NIO_PIB, 
Visiting investigator @MSKCancerCenter, 
YOC Member @myESMO 
#Sarcoma #melanoma  
He/him ??????????